Peter is a current Director and the inaugural and Past-Chair of Linear Clinical Research (Linear), a wholly owned subsidiary of the Harry Perkins Institute of Medical Research (Perkins) and has been involved with Linear since its inception.
He is the Chief Executive Officer and Director of the Perkins and a Professor of Medicine at University of Western Australia (UWA). He graduated in medicine from UWA then undertook specialist training in endocrinology at Royal Melbourne Hospital in the 90s. He completed PhD studies at the Walter and Eliza Hall Institute of Medical Research and postdoctoral studies at Harvard Medical School, before returning to Perth.
Peter is internationally recognised for his RNA-based research on hormone-dependent cancers (breast and prostate) and more lately on poor prognostic tumours (liver, head and neck cancer). As Laboratory Head of Cancer Medicine at the Perkins, he and his team are developing microRNA-based therapies for these solid tumours that are being translated to the bedside.
Peter is a Board Member of the national Association of Australian Medical Research Institutes, fellow of the Australian Academy of Health and Medical Sciences, a Graduate of the Australian Institute of Company Directors and co-founder of miReven, a biotech company focused on developing a novel way to treat liver cancer with micro RNA’s. Peter was appointed an Officer of the Order of Australia in the Australia Day 2021 Honours List for distinguished service to medicine, health and medical research as a physician scientist, to professional societies, and to tertiary education.